← Leaderboards
Adrienne M. Dorrance
Ohio State University
$2,314,541
Attributed
$4,119,005
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,119,005 · 2
By mechanism
R01$4,119,005 · 2
Top collaborators
- Ramiro Garzon4 shared
- Parvathi Ranganathan4 shared
Most similar at Ohio State University
Same institution · by research overlap
- Ramiro Garzon$6,835,986
- Michael A Caligiuri$65,062,344
- Danilo Perrotti$4,143,140
- Clara D Bloomfield$12,059,354
- Susan P Whitman$649,094
Others in their field
Other Rising Stars on “Growth Factor”
- Supriya Menezes · The Emmes Company, Llc$18,394,958
- Sunni L. Mumford · University Of Pennsylvania$6,439,627
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Ronald F Piccolo · Icamr, Inc.$4,979,557
- John Allgair · Icamr, Inc.$4,979,557
- Tawny H Olore · Icamr, Inc.$4,979,557
Research focus
Growth FactorCellsHematological DiseasePublishingPlayNovel TherapeuticsRecombinantsMouse ModelPhysiologicalProteinsResponsePreclinical StudyBiologyPhenotypeCell PhysiologyAngiogenesisEpitheliumHematopoietic Stem CellsBlast CellBindingCell GrowthAllogenicAcute Myeloid Leukemia CellAcute Graft Versus Host Disease
Grant awards (8)
Developing novel therapies to improve blood stem cell transplantation outcomes$630,428
R01 · FY2025 · HL
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation$361,374
R01 · FY2025 · CA · contact PI
Developing novel therapies to improve blood stem cell transplantation outcomes$620,713
R01 · FY2024 · HL
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation$325,196
R01 · FY2024 · CA · contact PI
Developing novel therapies to improve blood stem cell transplantation outcomes$671,563
R01 · FY2023 · HL
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation$357,254
R01 · FY2023 · CA · contact PI
Developing novel therapies to improve blood stem cell transplantation outcomes$783,992
R01 · FY2022 · HL
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation$368,485
R01 · FY2022 · CA · contact PI